Julian JA - Search Results

1

An open-label randomized controlled trial of low molecular weight heparin compared to heparin and coumadin for the treatment of venous thromboembolic events in children: the REVIVE trial.

Massicotte P, Julian JA, Gent M, Shields K, Marzinotto V, Szechtman B, Andrew M; REVIVE Study Group. Massicotte P, et al. Among authors: julian ja. Thromb Res. 2003 Jan 25;109(2-3):85-92. doi: 10.1016/s0049-3848(03)00059-8. Thromb Res. 2003. PMID: 12706636 Clinical Trial.

2

The occurrence of subsequent malignancy in patients presenting with deep vein thrombosis: results from a historical cohort study.

Rajan R, Levine M, Gent M, Hirsh J, Geerts W, Skingley P, Julian J. Rajan R, et al. Thromb Haemost. 1998 Jan;79(1):19-22. Thromb Haemost. 1998. PMID: 9459315 Clinical Trial.

3

A novel antithrombin-heparin covalent complex: antithrombotic and bleeding studies in rabbits.

Chan AK, Berry L, Klement P, Julian J, Mitchell L, Weitz J, Hirsh J, Andrew M. Chan AK, et al. Blood Coagul Fibrinolysis. 1998 Oct;9(7):587-95. Blood Coagul Fibrinolysis. 1998. PMID: 9863706

4

A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism.

Kearon C, Gent M, Hirsh J, Weitz J, Kovacs MJ, Anderson DR, Turpie AG, Green D, Ginsberg JS, Wells P, MacKinnon B, Julian JA. Kearon C, et al. Among authors: julian ja. N Engl J Med. 1999 Mar 25;340(12):901-7. doi: 10.1056/NEJM199903253401201. N Engl J Med. 1999. PMID: 10089183 Free article. Clinical Trial.

5

The effects of low-intensity warfarin on coagulation activation in patients with antiphospholipid antibodies and systemic lupus erythematosus.

Douketis JD, Crowther MA, Julian JA, Stewart K, Donovan D, Kaminska EA, Laskin CA, Ginsberg JS. Douketis JD, et al. Among authors: julian ja. Thromb Haemost. 1999 Sep;82(3):1028-32. Thromb Haemost. 1999. PMID: 10494759 Clinical Trial.

6

Analysis of warfarin therapy in pediatric patients: A prospective cohort study of 319 patients.

Streif W, Andrew M, Marzinotto V, Massicotte P, Chan AK, Julian JA, Mitchell L. Streif W, et al. Among authors: julian ja. Blood. 1999 Nov 1;94(9):3007-14. Blood. 1999. PMID: 10556183 Free article.

7

Pharmacokinetic profile of a low-molecular weight heparin (reviparin) in pregnant patients. A prospective cohort study.

Crowther MA, Spitzer K, Julian J, Ginsberg J, Johnston M, Crowther R, Laskin C. Crowther MA, et al. Thromb Res. 2000 Apr 15;98(2):133-8. doi: 10.1016/s0049-3848(99)00228-5. Thromb Res. 2000. PMID: 10713314

8

The effects of hormone replacement therapy on thrombin generation, fibrinolysis inhibition, and resistance to activated protein C: prospective cohort study and review of literature.

Douketis JD, Gordon M, Johnston M, Julian JA, Adachi JR, Ginsberg JS. Douketis JD, et al. Among authors: julian ja. Thromb Res. 2000 Jul 1;99(1):25-34. doi: 10.1016/s0049-3848(00)00217-6. Thromb Res. 2000. PMID: 11012376

9

Treatment of warfarin-associated coagulopathy with oral vitamin K: a randomised controlled trial.

Crowther MA, Julian J, McCarty D, Douketis J, Kovacs M, Biagoni L, Schnurr T, McGinnis J, Gent M, Hirsh J, Ginsberg J. Crowther MA, et al. Lancet. 2000 Nov 4;356(9241):1551-3. doi: 10.1016/S0140-6736(00)03125-1. Lancet. 2000. PMID: 11075768 Clinical Trial.

10

Acquired activated protein C resistance is associated with lupus anticoagulants and thrombotic events in pediatric patients with systemic lupus erythematosus.

Male C, Mitchell L, Julian J, Vegh P, Joshua P, Adams M, David M, Andrew ME. Male C, et al. Blood. 2001 Feb 15;97(4):844-9. doi: 10.1182/blood.v97.4.844. Blood. 2001. PMID: 11159506 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

188 results

Search Page

Filters